Stocks · Real Estate · REIT - Healthcare Facilities
Healthcare Realty Trust Incorporated HR
$17.47 +0.23% Close, Oct 2, 2026 · NYSE · Market cap $6.13B
Low risk
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 22.6% from 4.0% a year earlier.
- Net debt is 6.5× EBITDA, a high level of leverage.
- Revenue over the last four quarters was $1.14B, down 6.3% from a year earlier.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 14%
- FCF growth (TTM, YoY)Bottom 34%
- Revenue growth, 3-year CAGRTop 36%
- Revenue growth accelerationBottom 45%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 6%
- Gross marginBottom 22%
- Operating marginBottom 46%
- Accruals (lower is better)Top 19%
- Net debt / EBITDA (lower is better)Bottom 43%
- Interest coverTop 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 24%
- Free-cash-flow yieldBottom 27%
- EBITDA / enterprise valueBottom 50%
- Sales / enterprise valueBottom 48%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 40%
- 6-month returnTop 43%
- 1-year return vs S&P 500Top 47%
- Distance from 52-week highBottom 48%
- Trend checklist (0–4)Top 41%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyBottom 8%
- Upside to consensus price targetTop 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 9%
- Maximum drawdown, 3 yearsTop 22%
- Beta vs S&P 500 (lower is better)Top 17%
- Net debt / EBITDA (lower is better)Bottom 43%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -6.4% | -6.3% | ↑ |
| Gross margin | -39.5% | 16.6% | ↑ |
| Operating margin | 4.0% | 22.6% | ↑ |
| FCF margin | 14.9% | 11.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -6.3% | -6.4% | ↑ | Bottom 14% |
| Gross margin | 16.6% | -39.5% | ↑ | Bottom 22% |
| Operating margin | 22.6% | 4.0% | ↑ | Bottom 46% |
| Net margin | -7.6% | -33.0% | ↑ | — |
| Free-cash-flow margin | 11.8% | 14.9% | ↓ | — |
| Return on invested capital | 48.0% | — | Top 6% | |
| Revenue growth, 3-year CAGR | 8.2% | — | Top 36% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.8%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 6.46×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 5.47%
- Net buyback yield (TTM)
- 3.43%
- Shareholder yield
- 8.90%
- Share count change, 1 year
- -2.1%
- Share count change, 3-year CAGR
- -3.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -0.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $21.88
- Target vs current price
- +25.2%
- Analysts with a rating
- 30
- Share rating Buy or Strong Buy
- 23%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | -3276.6% | -1.3% | -6.5% | -11.7% | — |
| Apr 30, 2026 | +5.1% | +1.3% | +9.6% | +8.9% | +16.6% |
| Feb 12, 2026 | -90.0% | +0.6% | +4.0% | +4.8% | +15.9% |
| Oct 30, 2025 | -661.3% | +0.1% | +1.0% | +3.0% | -5.7% |
| Jul 31, 2025 | -531.4% | -1.3% | +8.4% | +10.9% | +20.1% |
| May 1, 2025 | -55.2% | +2.3% | -2.1% | -6.4% | +0.8% |
| Feb 19, 2025 | -287.5% | -1.3% | -0.8% | -1.3% | -14.4% |
| Oct 30, 2024 | -394.1% | -2.8% | -3.1% | +2.3% | -6.2% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.13 | -$0.00 | -3276.6% | $281.8M |
| Apr 30, 2026 | $0.41 | $0.39 | +5.1% | $279.0M |
| Feb 12, 2026 | $0.04 | $0.40 | -90.0% | $286.3M |
| Oct 30, 2025 | -$0.17 | -$0.02 | -661.3% | $287.4M |
| Jul 31, 2025 | -$0.45 | -$0.07 | -531.4% | $287.1M |
| May 1, 2025 | -$0.13 | -$0.08 | -55.2% | $288.9M |
| Feb 19, 2025 | -$0.31 | -$0.08 | -287.5% | $300.1M |
| Oct 30, 2024 | -$0.26 | -$0.05 | -394.1% | $306.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 15.5× | — | — | Bottom 50% |
| EV / Sales | 9.18× | — | — | Bottom 48% |
| Free-cash-flow yield | 2.20% | — | — | Bottom 27% |
| Earnings yield | -1.50% | — | — | Bottom 24% |
P/E over the past five years
Range 26.6× – 88.2× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -4.9%
- 200-day average slope (20 days)
- +0.3%
- Distance from 50-day average
- -9.3%
- Distance from 200-day average
- -7.0%
- RSI (14)
- 21.4
- Relative volume
- 0.87×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 15.9%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.24
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- -20.1%
- Maximum drawdown, 3 years
- -26.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 28, 2021 | Mar 14, 2024 | -61.6% | 596 days | Not yet recovered |
| Nov 16, 2020 | Jan 11, 2021 | -12.7% | 37 days | 68 days (Apr 20, 2021) |
| Oct 2, 2020 | Oct 28, 2020 | -10.4% | 18 days | 9 days (Nov 10, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.13B
- EPS, diluted (TTM)
- -$0.26
- Revenue (TTM)
- $1.14B
- Dividend yield
- 5.50%
- 52-week range
- $16.31 – $22.04
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $534.8M | $932.6M | $1.34B | $1.27B | $1.18B |
| Gross profit | -$82.9M | -$317.6M | -$618.1M | -$555.4M | -$396.5M |
| Operating income | $85.7M | $78.7M | $49.8M | $36.4M | $94.9M |
| Net income | $66.7M | $40.9M | -$278.3M | -$654.5M | -$246.1M |
| EPS (diluted) | $0.45 | $0.15 | -$0.74 | -$1.81 | -$0.71 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $315.4M | $309.8M | $299.0M | $297.5M | $297.8M | $286.3M | $279.0M | $281.8M |
| Net income | -$93.0M | -$106.8M | -$44.9M | -$157.9M | -$57.7M | $14.4M | -$56,000 | -$43.5M |
| EPS (diluted) | -$0.26 | -$0.31 | -$0.13 | -$0.45 | -$0.17 | $0.04 | -$0.00 | -$0.13 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $232.6M | $272.7M | $499.8M | $501.6M | $457.1M |
| Capital expenditure | -$100.7M | -$163.5M | -$231.0M | -$249.0M | -$330.2M |
| Free cash flow | $131.9M | $109.2M | $268.8M | $252.6M | $126.9M |
| Dividends paid | -$175.5M | -$1.41B | -$472.2M | -$457.9M | -$386.9M |
| Net share buybacks | $327.3M | $19.7M | -$2.2M | -$519.2M | -$4.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $19.0M
- Total assets
- $9.00B
- Total liabilities
- $4.73B
- Total debt
- $4.40B
- Net debt
- $4.38B
- Shareholders’ equity
- $4.22B
As of Jun 30, 2026 (filed Jul 30, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 11, 2026 | $0.24 | Aug 26, 2026 |
| May 11, 2026 | $0.24 | May 22, 2026 |
| Feb 24, 2026 | $0.24 | Mar 11, 2026 |
| Nov 10, 2025 | $0.24 | Nov 21, 2025 |
| Aug 14, 2025 | $0.24 | Aug 28, 2025 |
| May 12, 2025 | $0.31 | May 23, 2025 |
| Mar 3, 2025 | $0.31 | Mar 19, 2025 |
| Nov 12, 2024 | $0.31 | Nov 27, 2024 |
Short interest
- Shares sold short
- 16,109,127
- Days to cover
- 4.91
- Change vs previous report
- -4.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Dec 16, 2014
- 1-for-2